If steps are taken to decrease potential risks, ECT is generally accepted to be relatively safe during all trimesters of pregnancy, particularly when compared to pharmacological treatments.   Suggested preparation for ECT during pregnancy includes a pelvic examination , discontinuation of nonessential anticholinergic medication, uterine tocodynamometry, intravenous hydration, and administration of a nonparticulate antacid . During ECT, elevation of the pregnant woman's right hip, external fetal cardiac monitoring, intubation , and avoidance of excessive hyperventilation are recommended.  In many instances of active mood disorder during pregnancy, the risks of untreated symptoms may outweigh the risks of ECT. Potential complications of ECT during pregnancy can be minimized by modifications in technique. The use of ECT during pregnancy requires thorough evaluation of the patient’s capacity for informed consent.